Author

R. Rajwani

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Approach:deep learning· 1 Organism:Drosophila· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1

Frequent Co-Authors

G. K. H. Siu· 2 shared K. K.-G. Tam· 2 shared W.-C. Yam· 2 shared A. W.-t. Lee· 1 shared B. H. Nega· 1 shared C. M. K. Chu· 1 shared C. Sayada· 1 shared C. T. M. Chan· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

G. K. H. Siu

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Construction of lux-based promoter-reporter platforms in Mycobacterium bovis BCG for screening of drug repurposing small-molecule compounds as new anti-tuberculosis drugs

L. Zhu, A. W.-t. Lee, K. K.-L. WU, P. GAO, K. K.-G. Tam, R. Rajwani, G. C. CHABURTE, T. T.-L. NG, C. T. M. Chan, H.-Y. Lao, W.-C. Yam, R. Y.-T. Kao, G. K. H. Siu

This study constructs a lux-based promoter-reporter system to screen small-molecule compounds for anti-TB activity, identifying one antibiotic and two anti-virulence agents.

bioRxiv · Nov 5, 2021 · PreprintMicrobiology

Targeted Sequencing Workflows for Comprehensive Drug Resistance Profiling of Mycobacterium tuberculosis cultures using Illumina MiSeq and Nanopore MinION: Comparison of analytical and diagnostic performance, turnaround time and cost

K. Tafess, T. T. L. Ng, H. Y. Lao, K. S.-S. Leung, K. K.-G. Tam, R. Rajwani, S. T. Y. Tam, L. P. K. Ho, C. M. K. Chu, D. Gonzalez, C. Sayada, O. C.-K. Ma, B. H. Nega, G. Ameni, W.-C. Yam, G. K. H. Siu

This paper compares two sequencing workflows for drug resistance profiling of M. tuberculosis using Illumina MiSeq and Nanopore MinION, finding comparable accuracy with differences in speed and cost.

bioRxiv · Sep 8, 2019Microbiology

A Drosophila metainflammation-blood tumor model links aspirin-triggered eicosanoid-like mediators to immune signaling

S. Govind, S. Panettieri, I. Paddibhatla, J. Chou, R. Rajwani, R. S. Moore, T. Goncharuk, G. John

This paper uses a Drosophila model to show aspirin reduces metabolic inflammation and immune signaling by promoting 13-EFOX-L2 production, suggesting evolutionary conserved mechanisms for resolving inflammation.

bioRxiv · May 5, 2019Immunology